Interpreting Pediatric Exposure Targets

Why Exposure-Target Choice Matters

An adult exposure target is not a single, interchangeable measure of drug concentration. AUC summarizes exposure over time, while peak, trough, and time above a threshold describe different features of the concentration-time profile. Those features can diverge when pediatric and adult pharmacokinetics differ. For example, two profiles may have similar AUC but different peak-to-trough fluctuation or time spent above a concentration associated with a desired effect.

The practical question is therefore not simply whether a child’s AUC matches an adult value. It is whether the selected exposure measure is the one that supports the clinical target, and whether the pediatric profile meets that target. The calculations below use deliberately simplified, hypothetical profiles to make these distinctions explicit. The target values are illustrative, not recommendations for any medicine.

Definition: Over a dosing interval of length \(\tau\), AUC is the area under the concentration-time curve, commonly written \(AUC_{\tau}\). The peak is the maximum concentration in the interval, \(C_{\max}\), and the trough is the concentration immediately before the next dose, \(C_{\min}\) or \(C_{\text{trough}}\). Time above threshold, written \(T_{>C^*}\), is the duration in the interval for which concentration exceeds a specified threshold \(C^*\). Each metric has units: for example, \(AUC_{\tau}\) in mg·h/L, concentration in mg/L, and time above threshold in hours.

Assumptions for Interpreting a Profile

Exposure targets should be applied to a concentration-time profile generated under a clearly stated regimen and model. In the worked calculations, concentration declines mono-exponentially after the peak within a dosing interval:

C(t)=C_{\max}e^{-kt}, \qquad 0\leq t\leq \tau,

where \(k\) is the elimination rate constant in h\(^{-1}\), and \(t\) is time since the peak in hours. This is a simplifying one-compartment representation, not a default description of every pediatric drug profile. It assumes the profile is adequately represented by a single exponential over the interval, the dosing interval is correctly specified, and the relevant PK is stable across that interval. For steady-state repeated dosing with linear, time-invariant PK, the concentration at the end of the interval is the predose trough for the next dose. More complex absorption, distribution, nonlinear PK, or changing clearance may require metrics calculated directly from the full model-predicted profile instead.

Interpretation also depends on why the target was selected. AUC is appropriate when the evidence supports a relationship with total exposure; a peak target when the relevant criterion concerns maximum concentration; a trough target when the minimum concentration is clinically relevant; and a time-above-threshold target when duration above a specified level matters. These metrics should not be treated as equivalent merely because each is calculated from the same profile. Their clinical meaning must be justified by the evidence for the drug and intended use.

Worked Example: Similar AUC, Different Pediatric Profile

Suppose hypothetical adult and pediatric steady-state profiles have \(\tau=12\) h. The adult profile falls from \(C_{\max}=12\) mg/L to a predose trough of 4 mg/L. The pediatric profile falls from 16 mg/L to 2 mg/L. Assume each follows the mono-exponential model above. For illustration, suppose the target criteria are \(AUC_{\tau}=75\)–95 mg·h/L, \(C_{\max}\leq14\) mg/L, \(C_{\text{trough}}\geq3\) mg/L, and at least 8 h above \(C^*=5\) mg/L.

First calculate \(k\) from the peak and trough. For the adult profile,

k_{\text{adult}}=\frac{\ln(12/4)}{12} =\frac{\ln 3}{12}=0.09155\ \text{h}^{-1}.

For the pediatric profile,

k_{\text{pediatric}}=\frac{\ln(16/2)}{12} =\frac{\ln 8}{12}=0.1733\ \text{h}^{-1}.

Integrating the concentration curve gives \(AUC_{\tau}=(C_{\max}-C_{\text{trough}})/k\). Thus the adult AUC is \((12-4)/0.09155=87.38\) mg·h/L, and the pediatric AUC is \((16-2)/0.1733=80.79\) mg·h/L. Both fall within the illustrative AUC range.

For a declining exponential profile, the time above \(C^*\), when \(C_{\max}>C^*>C_{\text{trough}}\), is \(\ln(C_{\max}/C^*)/k\). The adult time is \(\ln(12/5)/0.09155=9.56\) h; the pediatric time is \(\ln(16/5)/0.1733=6.71\) h. The adult profile meets all four illustrative criteria. The pediatric profile meets the AUC criterion, but its peak exceeds 14 mg/L, its trough is below 3 mg/L, and its time above 5 mg/L is less than 8 h. Matching an AUC range alone therefore does not establish that the pediatric profile meets the other targets.

Why the Metrics Can Lead to Different Conclusions

The calculation rests on two results. Integrating the exponential profile gives

AUC_{\tau}=\int_0^{\tau}C_{\max}e^{-kt}\,dt =\frac{C_{\max}}{k}(1-e^{-k\tau}) =\frac{C_{\max}-C_{\text{trough}}}{k},

because \(C_{\text{trough}}=C_{\max}e^{-k\tau}\). To find the time above a threshold, set \(C(t)=C^*\) and solve:

C^*=C_{\max}e^{-kt} \quad\Longrightarrow\quad t=\frac{\ln(C_{\max}/C^*)}{k}.

This crossing time is the time above threshold if the profile starts above the threshold and falls through it before the interval ends. If \(C_{\max}\leq C^*\), time above threshold is zero; if the trough remains above \(C^*\), the time is the full interval \(\tau\). These boundary cases matter: applying the crossing formula without checking where the threshold lies relative to the peak and trough can produce an invalid duration.

AUC depends on both the concentration scale and the profile over the whole interval. Peak and trough focus on particular points, while time above threshold depends on the profile’s shape and where it crosses a chosen concentration. A change in clearance, distribution, absorption, or dosing interval may alter one metric more than another. Consequently, an adult target expressed as one metric cannot automatically be translated into a matching value of another metric in children.

Worked Example: Dose Scaling Gives Conflicting Target Requirements

Use the pediatric profile in the first example as the current prediction, and suppose dose changes scale all concentrations and AUC proportionally while leaving \(k\) and \(\tau\) unchanged. Let \(m\) be the new dose divided by the current dose. Under these assumptions, each concentration and \(AUC_{\tau}\) is multiplied by \(m\). Consider the same illustrative criteria: AUC 75–95 mg·h/L, peak no greater than 14 mg/L, trough at least 3 mg/L, and at least 8 h above 5 mg/L.

To match the point AUC target of 80 mg·h/L, the required multiplier is \(m=80/80.79=0.9902\). To remain within the AUC range, \(m\) must be between \(75/80.79=0.9283\) and \(95/80.79=1.176\). The peak constraint requires \(16m\leq14\), or \(m\leq0.875\). The trough constraint requires \(2m\geq3\), or \(m\geq1.500\). These constraints cannot be met together.

The time-above-threshold requirement also implies a distinct dose multiplier. Under proportional scaling, the time above 5 mg/L is \(\ln(16m/5)/0.1733\). Requiring that value to be at least 8 h gives

\frac{\ln(16m/5)}{0.1733}\geq8 \quad\Longrightarrow\quad m\geq\frac{5}{16}e^{0.1733(8)} \approx1.250.

That requirement conflicts with the peak limit \(m\leq0.875\), and it does not satisfy the trough requirement \(m\geq1.500\). The peak and trough constraints alone show the structural conflict: the current profile has \(C_{\text{trough}}/C_{\max}=2/16=0.125\), so attaining a trough of at least 3 mg/L would require a peak of at least \(3/0.125=24\) mg/L, above the allowed 14 mg/L. This is not a dose recommendation. It shows that proportional dose scaling cannot satisfy these hypothetical criteria simultaneously; the target basis, model, or regimen assumptions would need clinical and scientific review.

Diagnostics, Alternatives, and Limitations

Before interpreting an apparent mismatch between targets, check the profile and the calculation that produced it. Useful checks include verifying dose and sample times, confirming that a reported trough is truly predose, examining whether the model reproduces observed concentrations across the interval, and checking the units and definition of the target. For time above threshold, inspect whether the predicted profile crosses the threshold once, multiple times, or not at all. A single-exponential calculation is not appropriate if the profile has a substantial absorption phase, multiple peaks, or other features that change the crossing pattern.

The main alternative to selecting one summary measure is to evaluate the full concentration-time profile against the relevant exposure criteria. This can clarify how different metrics relate for a particular regimen, but it does not solve uncertainty about which criterion predicts clinical benefit or harm. If a target comes from adult data, its use in children depends on the justification for transporting that exposure-response evidence, not simply on the ability to compute the same metric in both populations. Predictions should also be interpreted with their uncertainty: a typical or mean profile does not show what fraction of children would meet a target.

Common limitations include uncertainty in the pediatric PK model, limited data in some ages, and differences between the modeled concentration and the biologically relevant exposure. A concentration threshold may be a useful operational target without being a universal boundary between response and no response. Likewise, matching an AUC does not guarantee matching effect, safety, or exposure distribution across children. Exposure calculations inform a decision; they do not replace evidence that the target is clinically meaningful.

Common pitfall: “The pediatric AUC is in the adult target range, so pediatric exposure is equivalent.” The correction is to specify which exposure metric the evidence supports, compare that metric using the pediatric profile, and assess any other clinically relevant constraints separately. AUC agreement is not proof that peak, trough, or time above threshold also agrees.

Worked Example: A Sample Taken Before the True Trough

For the pediatric profile above, the dose interval is 12 h and the predicted predose trough is 2 mg/L. Suppose a sample is collected at 9.5 h after the dose but is mistakenly labeled as the trough. The predicted concentration at that sampling time is

C(9.5)=16e^{-0.1733(9.5)} \approx3.09\ \text{mg/L}.

That sample exceeds the illustrative trough minimum of 3 mg/L, but it is not the predose concentration. At 12 h the predicted concentration is 2 mg/L, which does not meet the criterion. Comparing the 9.5 h sample with a predose target would therefore produce a misleading conclusion. The timing definition is part of the target and must match the observation or model output being assessed.

A Practical Interpretation Sequence

A disciplined interpretation keeps target definition, profile calculation, and decision distinct. The sequence below is useful when reviewing a pediatric exposure comparison.

State the target precisely.
Name the metric, threshold or range, units, dosing interval, and timing convention. Identify the evidence supporting that target.

Calculate it from the relevant profile.
Use the modeled or observed pediatric profile under the intended regimen; do not infer a peak, trough, or time-above-threshold result from AUC alone.

Check assumptions and data alignment.
Verify sample timing, model adequacy, units, and whether simplifying assumptions such as linear dose scaling are reasonable.

Compare criteria and state uncertainty.
Report which targets are met or not met, whether constraints conflict, and what uncertainty remains. Avoid turning a model prediction into a claim of clinical equivalence.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

A profile has \(C_{\max}=10\) mg/L, a trough of 2 mg/L, and \(k=0.10\) h\(^{-1}\). What is \(AUC_{\tau}\) under the mono-exponential model?
For the same profile, how long is concentration above 4 mg/L if the interval is long enough for the profile to cross that threshold?
A child’s AUC matches a target, but the predicted trough is below its specified minimum. Is the target met? Explain.
Under proportional dose scaling, a peak ceiling requires \(m\leq0.8\), while a trough minimum requires \(m\geq1.1\). What conclusion follows?

Solutions. (1) \(AUC_{\tau}=(10-2)/0.10=80\) mg·h/L. (2) The crossing time is \(\ln(10/4)/0.10=9.163\) h, so concentration is above 4 mg/L for about 9.16 h if the trough occurs later. (3) No. Matching AUC does not meet a separate trough criterion; the trough must be evaluated on its own terms. (4) No dose multiplier satisfies both constraints because no \(m\) can be at most 0.8 and at least 1.1 simultaneously. Under the assumed scaling, the criteria are incompatible.